Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001179110-16-028544

President and CEO acquired 50,765 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kumar Ramesh · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-07-29 Option exercise : show line 1 in the form +50,765 $4.10 $208,137 78,417 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-07-26 Option exercise : show line 2 in the form Subscription Right (right to buy) −41,475 $4.10 2016-07-26 41,475 0 D
2016-07-29 Option exercise : show line 3 in the form Warrants (right to buy) +38,071 $4.92 2021-07-27 38,071 38,071 D
Loading xslF345X03/edgar.xml…